Why cannabis-related psychosis can be difficult to diagnose early

Clinical and Sociodemographic Characteristics of Young People With Early Psychosis: Comparing Cannabis Users and Non-Users in a Specialized Early Intervention Setting.

Early intervention in psychiatry • • Observational • Highly Relevant
🤖

AI Summary

This retrospective study examined 509 young people aged 18–35 receiving early psychosis treatment, comparing those diagnosed with cannabis-induced psychotic disorder (CIPD), those with a non-substance-induced psychotic disorder and concurrent cannabis use (NSIPD+C), and those with a non-substance-induced psychotic disorder without reported concurrent cannabis use (NSIPD). The groups represented 33.3%, 7%, and 42.6% of participants, respectively. The study found no meaningful group differences in sociodemographic characteristics, duration of untreated psychosis, or measures of functioning.

People with NSIPD remained in treatment longer, showed greater treatment motivation, and were more likely to leave treatment in line with clinicians’ recommendations than participants in the CIPD and NSIPD+C groups. The authors conclude that these background and clinical measures do not reliably distinguish the type of psychosis when cannabis use and psychotic symptoms occur together. For cannabis users and families, the findings highlight why early professional assessment is important: cannabis involvement alone may not clarify diagnosis, and low-threshold early-intervention services may help people access care before delays become substantial.

💡 Key Findings

1
Among young people with early psychosis, cannabis-induced psychotic disorder and psychotic disorders with concurrent cannabis use were common diagnostic groups, but the abstract does not establish that cannabis caused psychosis in every user.
High
80%
2
Sociodemographic characteristics, duration of untreated psychosis, and functioning scores did not distinguish the diagnostic groups when cannabis use and psychotic symptoms occurred together.
High
80%
3
The non-substance-induced psychotic disorder group had longer treatment, greater treatment motivation, and more clinician-recommended discharges than the cannabis-related comparison groups.
High
80%
4
The authors emphasize that early-intervention services with low-threshold access may support timely care, since duration of untreated psychosis did not differ across diagnoses.
Good
75%

📄 Original Abstract

Despite the high prevalence of comorbid cannabis use at first onset of psychotic symptoms, high transition rates from cannabis-induced psychosis to schizophreniform psychoses and bipolar disorder, and evidence of cannabis use as a risk factor in developing primary psychosis, only a few studies have addressed the difficulties in differential diagnosis focusing on the early stages of the disease. The present study is the first to date to examine clinical and sociodemographic characteristics of individuals with early psychosis, comparing cannabis-induced psychotic disorder (CIPD), non-substance-induced psychotic disorder with concurrent cannabis use (NSIPD+C), and non-substance-induced psychotic disorder (NSIPD). A retrospective chart review of patients aged 18-35 with early psychosis who received inpatient treatment at FRITZ Early Intervention Center between December 2016 and September 2021 was conducted. Sociodemographic characteristics included age, biological sex, family history of psychiatric illness, migration background, living status, education/work status. Clinical characteristics included insight into illness, duration of untreated psychosis (DUP), social functioning, pathway to treatment, treatment motivation, treatment recommendation, and type of discharge. Of 509 participants, 42.6% had a diagnosis of NSIPD, 33.3% of CIPD, 7% of NSIPD+C. NSIPD had a significantly longer treatment duration compared to CIPD, a higher treatment motivation, and a higher discharge in accordance with clinicians' recommendation compared to both CIPD and NSIPD+C. No significant group differences were found in sociodemographic characteristics, DUP, and functioning scores. The examined sociodemographic parameters as well as level of functioning and DUP do not aid in the differential diagnostic classification when cannabis use and psychotic symptoms occur simultaneously. The absence of differences in DUP across diagnoses may reflect the efficacy of low-threshold access provided by FRITZ and further supports the need for comprehensive implementation of early intervention services.

Explore More Research

Stay informed about the latest cannabis science.

Your stash, decoded.